8-KLeadership Changes

CME GROUP INC. 8-K Report, Executive Changes (Dec 11, 2014)

Filed December 11, 2014For Securities:CME

Summary

This Form 8-K filing from CME Group Inc. (CME) reports on a key executive transition within the company. Specifically, it confirms the effective date of the Chief Financial Officer (CFO) transition, with John W. Pietrowicz assuming the CFO role from James E. Parisi. Mr. Parisi, who had previously announced his intention to retire, will officially step down as CFO on December 10, 2014, but will remain with the company until December 31, 2014, to ensure a smooth handover. This transition is part of a previously announced succession plan. The filing also provides background on Mr. Pietrowicz, highlighting his extensive experience within CME Group since 2003, including his recent role as Senior Managing Director of Business Development and Corporate Finance. His compensation as CFO will be aligned with other senior executives. Investors should note this change in leadership for the financial helm of CME Group, as it represents a continuity of leadership with an internal promotion.

Key Highlights

  • 1Effective December 10, 2014, John W. Pietrowicz officially became the Chief Financial Officer (CFO) of CME Group Inc.
  • 2James E. Parisi transitioned out of the CFO role as planned, effective December 10, 2014.
  • 3Mr. Parisi will continue to be employed by CME Group until December 31, 2014, to facilitate a transition period.
  • 4John W. Pietrowicz has a long tenure with CME Group, having joined in 2003 and holding various senior finance and business development roles.
  • 5Mr. Pietrowicz's compensation as CFO will be consistent with other Senior Managing Directors.
  • 6There are no reported family relationships or undisclosed transactions between Mr. Pietrowicz and CME Group's executives or directors.

Frequently Asked Questions